Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Biotechnologie”
Aandelen in “Biotechnologie”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Biotechnologie”
Toon enkel gratis nieuws
14:26 ·
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
· Persbericht
14:26 ·
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
· Persbericht
14:24 ·
iTeos Therapeutics Announces $120 Million Registered Direct Offering
· Persbericht
14:05 ·
Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
· Persbericht
14:00 ·
Curis to Present Updated Data from the TakeAim Leukemia Study
· Persbericht
13:30 ·
Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
· Persbericht
13:05 ·
REGENXBIO to Participate in Upcoming Investor Conferences
· Persbericht
08:15 ·
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
· Persbericht
08:00 ·
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
· Persbericht
9/05 ·
DBV Technologies to Participate in Upcoming Investor Conferences
· Persbericht
9/05 ·
Nektar Therapeutics Reports First Quarter 2024 Financial Results
· Persbericht
9/05 ·
PacBio Announces First Quarter 2024 Financial Results
· Persbericht
9/05 ·
SenesTech Announces First Quarter 2024 Financial Results
· Persbericht
9/05 ·
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
· Persbericht
9/05 ·
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
· Persbericht
9/05 ·
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights
· Persbericht
9/05 ·
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
· Persbericht
9/05 ·
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
· Persbericht
9/05 ·
Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
· Persbericht
9/05 ·
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
· Persbericht
9/05 ·
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adults
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe